Reports of isoflavone supplementation in patients with PCa include multiple randomized controlled trials that suggest that isoflavones show a suppressive effect on PCa progression based on biomarkers, such as serum PSA and testosterone levels [117,118,119,120], although the results have been inconsistent [121]. Here, KLK3 is linked to posterior cortical atrophy.